Pedro Rivera, MD
Critical Care Medicine · New York, NYNPI 1174729396
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Johnson & Johnson at 36.0% of the total. Reporting peaked in 2019 at $1,348 and has fallen 84.8% since, to $206 in 2025.
Across 206 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$584
- Pfizer$566
- Melinta Therapeutics, LLC$426
- Merck$396
- CSL Behring$305
- plus $472 from 8 others
What the payments were for
- Food & beverage$4,276100%
- Education$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 61 | $1,547 |
| AbbVie(2 entities) | 45 | $584 |
| Pfizer | 33 | $566 |
| Melinta Therapeutics, LLC | 13 | $426 |
| Merck | 20 | $396 |
| CSL Behring | 10 | $305 |
| E.r. Squibb & Sons, L.L.C. | 10 | $172 |
| Chiesi USA, Inc. | 8 | $164 |
| Vapotherm Inc | 1 | $30 |
| Gilead | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Nabriva Therapeutics, PLC | 1 | $19 |
How this compares
$4,296 in reported general payments places this provider in the 85th percentile of 442 critical care medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in New York
- Roxana SulicaNew York$211K
- Anna PodolanczukNew York$116K
- Jan BakkerNew York$49K
- Robert SladenNew York$40K
- Neil HalpernNew York$29K
- Singwu LawNew York$20K
- Peter SalgoNew York$18K
- Stephen PastoresNew York$17K
- Arvin ChinNew York$17K
- Nina PatelNew York$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.